The EU Drugs Strategy provides a political framework and priorities for action in the field of drug policies for the period 2013–2020. It is structured around two policy fields: drug demand reduction and drug supply reduction; and three cross-cutting themes: coordination, international cooperation and information, research, monitoring and evaluation. The strategy is implemented through two EU Action Plans on Drugs, the first of which (2013–2016) will come to a close this year. In view of preparing the second action plan (2017–2020), the European Commission has launched a public consultation, which will run until Europe Day (9 May).
All EU and non-EU citizens and stakeholders are invited to contribute to this consultation. Contributions are sought from individuals, local, regional and national authorities, international and regional organisations, intergovernmental and non-governmental organisations, academic institutions, third countries, social partners and civil society.
The consultation seeks to gather views on the five objectives of the EU Drugs Strategy (and corresponding actions) and on the following evaluation criteria: effectiveness, efficiency, relevance, coherence and EU added value. The public consultation will provide an important contribution to the evidence base for the mid-term evaluation of the EU Drugs Strategy and Action Plan (2013–2016).
